The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Based on the Anebulo Pharmaceuticals Inc stock forecast from 0 analysts, the average analyst target price for Anebulo Pharmaceuticals Inc is not available over the next 12 months. Anebulo Pharmaceuticals Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Anebulo Pharmaceuticals Inc is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Anebulo Pharmaceuticals Inc’s stock price was USD 1.80. Anebulo Pharmaceuticals Inc’s stock price has changed by -6.26% over the past week, -9.10% over the past month and -36.17% over the last year.
No recent analyst target price found for Anebulo Pharmaceuticals Inc
No recent average analyst rating found for Anebulo Pharmaceuticals Inc
Company Overview Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas. Address: 1017 Ranch Road 620 South, Lakeway, TX, United States, 78734 Read Less
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor a...Read More
Frequently Asked Questions About Anebulo Pharmaceuticals Inc (ANEB) Stock
Stock Target Advisor's fundamental analysis for Anebulo Pharmaceuticals Inc's stock is Very Bearish.
Unfortunately we do not have enough data on ANEB's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ANEB's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ANEB's stock to indicate if its overvalued.
The last closing price of ANEB's stock was USD 1.80.
The most recent market capitalization for ANEB is USD 0.05B.
Unfortunately we do not have enough analyst data on ANEB's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Anebulo Pharmaceuticals Inc's stock.
As per our most recent records Anebulo Pharmaceuticals Inc has 2 Employees.
Anebulo Pharmaceuticals Inc's registered address is 1017 Ranch Road 620 South, Lakeway, TX, United States, 78734.
You can get more information about it from Anebulo Pharmaceuticals Inc's website at https://www.anebulo.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Anebulo Pharmaceuticals Inc (ANEB) Stock
Stock Target Advisor's fundamental analysis for Anebulo Pharmaceuticals Inc's stock is Very Bearish.
Unfortunately we do not have enough data on ANEB's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ANEB's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ANEB's stock to indicate if its overvalued.
The last closing price of ANEB's stock was USD 1.80.
The most recent market capitalization for ANEB is USD 0.05B.
Unfortunately we do not have enough analyst data on ANEB's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Anebulo Pharmaceuticals Inc's stock.
As per our most recent records Anebulo Pharmaceuticals Inc has 2 Employees.
Anebulo Pharmaceuticals Inc's registered address is 1017 Ranch Road 620 South, Lakeway, TX, United States, 78734.
You can get more information about it from Anebulo Pharmaceuticals Inc's website at https://www.anebulo.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ANEB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
